At CCMB, nearly 900 doses of injectable treatments are carefully prepared each week inside a specialized “clean room”. With over 8,000 Manitobans diagnosed with cancer each year, our teams are working together to ensure patients receive the right care, closer to home. www.cbc.ca/news/canada/...

The TRACTION trial—co-led by CancerCare Manitoba researchers presented yesterday at #ASH2025. Findings from 8,400 patients show pre-op tranexamic acid reduces blood transfusion with no increase in blood clots, even in cancer patients. A major step towards safer surgeries and sustainable blood supply

A recent study from our team confirms that isatuximab, a common myeloma treatment— can now be safely delivered in just 30 minutes instead of 75 minutes. Why it matters: quicker appointments, more comfortable experiences, and more capacity to care for Manitobans. #patientcare #cancercare

🎓 Exciting news! #PROMISE Madox's Warriors Graduate Studentship officially launches today! Check out the details and help spread the word. #MadoxsWarriors #GradStudentship #CHRIM #CCMB #CancerResearch @um-radyfhs.bsky.social @umbmg.bsky.social @cancercaremb.bsky.social @chrimanitoba.bsky.social

🍁Meet the Team Canada of Cancer Research: A Q&A with Dr. Versha Banerji🍁 After early setbacks, Dr. Banerji found her calling in hematology. Through MOHCCN, she and her team study immune dysfunction in chronic lymphocytic leukemia to develop more targeted cancer therapies. tinyurl.com/bdf7w8cv

We are pleased to welcome Dr. Kent Stobart as CancerCare Manitoba’s new President and CEO. A pediatric oncologist and a health care leader, Dr. Stobart brings passion, experience, and a commitment to advancing cancer care and research for all Manitobans. 💙